Literature DB >> 9681422

Guidance for human somatic cell therapy and gene therapy. March 1998. Center for Biologics Evaluation and Research, Food and Drug Administration.

.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach

Mesh：

Year:  1998        PMID： 9681422     DOI： 10.1089/hum.1998.9.10-1513

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN： 1043-0342            Impact factor:   5.695


× No keyword cloud information.
  13 in total

1.  Brucella abortus strain RB51 leucine auxotroph as an environmentally safe vaccine for plasmid maintenance and antigen overexpression.

Authors:  Parthiban Rajasekaran; Mohamed N Seleem; Andrea Contreras; Endang Purwantini; Gerhardt G Schurig; Nammalwar Sriranganathan; Stephen M Boyle
Journal:  Appl Environ Microbiol       Date:  2008-10-03       Impact factor: 4.792

Review 2.  New generation of plasmid backbones devoid of antibiotic resistance marker for gene therapy trials.

Authors:  Gaëlle Vandermeulen; Corinne Marie; Daniel Scherman; Véronique Préat
Journal:  Mol Ther       Date:  2011-08-30       Impact factor: 11.454

Review 3.  Establishing a Quality Control System for Stem Cell-Based Medicinal Products in China.

Authors:  Bao-Zhu Yuan
Journal:  Tissue Eng Part A       Date:  2015-01-28       Impact factor: 3.845

Review 4.  Manufacturing genetically modified T cells for clinical trials.

Authors:  A P Gee
Journal:  Cancer Gene Ther       Date:  2015-01-30       Impact factor: 5.987

Review 5.  Downstream processing and chromatography based analytical methods for production of vaccines, gene therapy vectors, and bacteriophages.

Authors:  Petra Kramberger; Lidija Urbas; Aleš Štrancar
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus.

Authors:  K N Wills; I A Atencio; J B Avanzini; S Neuteboom; A Phelan; J Philopena; S Sutjipto; M T Vaillancourt; S F Wen; R O Ralston; D E Johnson
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 7.  Biodistribution studies for cell therapy products: Current status and issues.

Authors:  Yoshiteru Kamiyama; Yoichi Naritomi; Yuu Moriya; Syunsuke Yamamoto; Tsukasa Kitahashi; Toshihiko Maekawa; Masahiro Yahata; Takeshi Hanada; Asako Uchiyama; Akari Noumaru; Yoshiyuki Koga; Tomoaki Higuchi; Masahiko Ito; Hiroyuki Komatsu; Sosuke Miyoshi; Sadaaki Kimura; Nobuhiro Umeda; Eriko Fujita; Naoko Tanaka; Taku Sugita; Satoru Takayama; Akihiko Kurogi; Satoshi Yasuda; Yoji Sato
Journal:  Regen Ther       Date:  2021-07-12       Impact factor: 3.419

8.  Regulations and guidelines governing stem cell based products: Clinical considerations.

Authors:  Bobby George
Journal:  Perspect Clin Res       Date:  2011-07

Review 9.  Therapies targeting DNA and RNA in Huntington's disease.

Authors:  Edward J Wild; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2017-09-12       Impact factor: 44.182

Review 10.  Contemporary Transposon Tools: A Review and Guide through Mechanisms and Applications of Sleeping Beauty, piggyBac and Tol2 for Genome Engineering.

Authors:  Nicolás Sandoval-Villegas; Wasifa Nurieva; Maximilian Amberger; Zoltán Ivics
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.